Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG:2315)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
30.16
-1.84 (-5.75%)
Nov 21, 2025, 11:59 AM HKT

HKG:2315 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
479.57403.85417.66626.62466.45750.04
Short-Term Investments
7.277.257.899.15106.98207.37
Trading Asset Securities
--8.498.2--
Cash & Short-Term Investments
486.84411.1434.04643.97573.42957.41
Cash Growth
14.80%-5.29%-32.60%12.30%-40.11%-
Accounts Receivable
201.08229.61142.38107.68103.0967.23
Other Receivables
23.0911.046.044.1714.9614.7
Receivables
224.18240.65148.43111.85118.0581.93
Inventory
7.655.399.923.7321.6510.21
Other Current Assets
167.38159.41130.69139.74161.1198.08
Total Current Assets
889.87816.54723.05919.3874.241,148
Property, Plant & Equipment
1,3531,3491,4511,5991,3911,136
Long-Term Investments
147.89222.61241.24250.819.6910.09
Other Intangible Assets
16.9820.6728.1330.656.062.43
Long-Term Deferred Tax Assets
0.540.96----
Other Long-Term Assets
79.355.066.16-21.8630.77
Total Assets
2,4882,4152,4492,8002,3032,327
Accounts Payable
104.62115.48175.23146.19102.4487.6
Accrued Expenses
25.8430.1827.8951.6253.6627.41
Current Portion of Long-Term Debt
153.8208.14176.84126.67--
Current Portion of Leases
30.7317.8626.3644.9426.914.11
Current Income Taxes Payable
8.5912.814.514.25.021.42
Current Unearned Revenue
109.08102.1969.2256.3861.5847.51
Other Current Liabilities
38.6148.2697.56176.06196.96150.42
Total Current Liabilities
471.26534.91577.62606.05446.56328.47
Long-Term Debt
248.01193.84173.9152.17--
Long-Term Leases
181.64150.45167.01191.5162.966.81
Long-Term Unearned Revenue
83.9784.987.0789.9392.890.12
Long-Term Deferred Tax Liabilities
--1.9---
Other Long-Term Liabilities
606.55612.62651.48709.36448.55382.88
Total Liabilities
1,5911,5771,6591,6491,051868.28
Common Stock
399.4399.4399.4399.4374.93360
Additional Paid-In Capital
1,9921,9921,9921,9921,5161,219
Retained Earnings
-1,706-1,754-1,787-1,404-802.32-256.75
Treasury Stock
-40.18-32.77-27.18-18.99--
Comprehensive Income & Other
246.7229.3209.09178.32159.03130.69
Total Common Equity
892.04834.06785.891,1461,2471,453
Minority Interest
4.554.554.554.554.764.83
Shareholders' Equity
896.58838.6790.441,1511,2521,458
Total Liabilities & Equity
2,4882,4152,4492,8002,3032,327
Total Debt
614.18570.28544.11415.2889.880.92
Net Cash (Debt)
-127.34-159.18-110.07228.69483.62876.5
Net Cash Growth
----52.71%-44.82%-
Net Cash Per Share
-0.32-0.40-0.280.601.336.79
Filing Date Shares Outstanding
399.4399.4399.4399.4396.69129.06
Total Common Shares Outstanding
399.4399.4399.4399.4374.93129.06
Working Capital
418.61281.62145.43313.25427.68819.17
Book Value Per Share
2.232.091.972.873.3311.26
Tangible Book Value
875.06813.39757.761,1161,2411,451
Tangible Book Value Per Share
2.192.041.902.793.3111.24
Machinery
-1,5021,4371,2081,107849.69
Construction In Progress
-1.95.19268.29181.96210.83
Leasehold Improvements
-232.8240.53161.75166.4344.07
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.